Access Bio, Inc. (KOSDAQ:950130)
2,360.00
+15.00 (0.64%)
Aug 11, 2026, 2:08 PM KST
Access Bio Market Cap
Access Bio has a market cap or net worth of 82.48 billion as of August 10, 2026. Its market cap has decreased by -56.49% in one year.
Market Cap
82.48B
Enterprise Value
-249.10B
Revenue
14.94B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,360.00
ChartMarket Cap Chart
Since May 30, 2013, Access Bio's market cap has decreased from 269.10B to 82.48B, a decrease of -69.35%. That is a compound annual growth rate of -8.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 82.48B | -38.29% |
| Dec 30, 2025 | 133.66B | -26.78% |
| Dec 30, 2024 | 182.55B | -39.72% |
| Dec 28, 2023 | 302.84B | -26.91% |
| Dec 29, 2022 | 414.36B | -27.26% |
| Dec 30, 2021 | 569.63B | -27.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| T&R Biofab | 118.21B |
| Osang Healthcare Co.,Ltd | 95.80B |
| Ray Co., Ltd. | 84.30B |
| P&S Robotics | 69.43B |
| Sugentech | 68.50B |
| DRTECH | 65.95B |
| LabGenomics | 65.48B |
| Humasis | 51.94B |